These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8926403)

  • 1. [Evaluation of neo-adjuvant therapy (NAT) applied to clinical stage III of lung cancer at our center].
    Yamamoto M; Mikami I; Nishimura H; Akiyama H; Mazaki Y; Haraguchi H; Tanaka S
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Mar; 44(3):317-9. PubMed ID: 8926403
    [No Abstract]   [Full Text] [Related]  

  • 2. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
    Komiya T; Hosono Y; Hirashima T; Masuda N; Yasumitsu T; Nakagawa K; Kikui M; Ohno A; Fukuoka M; Kawase I
    Clin Cancer Res; 1997 Oct; 3(10):1831-5. PubMed ID: 9815570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
    Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
    Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer patients with chronic obstructive pulmonary disease.
    Kurishima K; Satoh H; Ishikawa H; Yamashita YT; Homma T; Ohtsuka M; Sekizawa K
    Oncol Rep; 2001; 8(1):63-5. PubMed ID: 11115570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Postoperative adjuvant therapy for 189 patients with completely resected non-small cell lung cancer of stage III(A)].
    Li Q; Gao JM; Liang PY; Xie FY; Liu GZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1463-6. PubMed ID: 15566658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of clarithromycin on prolonging the life expectancy of patients with primary lung cancer].
    Mikasa K; Sawaki M; Kita E; Hamada K; Sakamoto M; Konishi M; Maeda K; Teramoto S; Tsujimoto M; Mori K; Ueda K; Fukuoka K; Segawa K; Kataoka T; Narita N
    Jpn J Antibiot; 1997 Mar; 50 Suppl A():45-8. PubMed ID: 9597439
    [No Abstract]   [Full Text] [Related]  

  • 7. BCG immunotherapy of lung cancer in a district oncology dispensary. I. Study of 860 patients with histologic diagnosis.
    Hadźiev S; Mandulova P; Kavaklieva-Dimitrova J; Penev K; Spassova M; Madźarova S
    Neoplasma; 1982; 29(1):93-110. PubMed ID: 6280082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of long-term results of surgical treatment of lung cancer].
    Lambrecht W; Wojcieszko A; Cieśliński K
    Pol Merkur Lekarski; 1997 Dec; 3(18):271-3. PubMed ID: 9523465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the surgical and combined treatments of lung cancer].
    Vagner RI; Gremilov VA; Barchuk AS; Baĭkova VS
    Vopr Onkol; 1977; 23(2):68-73. PubMed ID: 404763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathological variability and cancer treatment in lung cancer].
    Kodama T
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2708-17. PubMed ID: 3019250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchogenic carcinoma in patients age 30 and younger.
    Whooley BP; Urschel JD; Antkowiak JG; Takita H
    Ann Thorac Cardiovasc Surg; 2000 Apr; 6(2):86-8. PubMed ID: 10870000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer survival in Norway, 1997-2011: from nihilism to optimism.
    Nilssen Y; Strand TE; Fjellbirkeland L; Bartnes K; Møller B
    Eur Respir J; 2016 Jan; 47(1):275-87. PubMed ID: 26541525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined treatment of lung cancer].
    Trakhtenberg AKh; Kiseleva ES; Kharchenko VP; Zakharchenkov AV; Barchuk AS
    Vopr Onkol; 1987; 33(10):25-30. PubMed ID: 3686904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined multimodality treatment for non-small cell lung cancer--with special reference to pre- and post-operative adjuvant therapy].
    Watanabe Y
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2555-63. PubMed ID: 7979413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atelectasis: positive or negative prognostic factor on outcome of patients with non-small cell lung cancer?
    Tepavac A; Secen N; Sazdanic Velikic D; Popovic G; Perin B
    J BUON; 2010; 15(4):679-83. PubMed ID: 21229629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgery and adjuvant therapy of non-small cell lung cancer].
    Watanabe Y; Yamada T; Ichihashi T; Hashizume Y; Iwa T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1534-46. PubMed ID: 3524465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Postoperative irradiation in the combined treatment of lung cancer patients].
    Kolesnikov IS; Strashinin AI; Shalaev SA; Zhdanova NV
    Vopr Onkol; 1982; 28(8):20-5. PubMed ID: 7113065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
    Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of postoperative CDDP-based chemotherapy/chemoradiotherapy vs short-term immunochemotherapy in lung cancer.
    Sagawa M; Sato M; Fujimura S; Usuda K; Kondo T; Tanita T; Takahashi S; Ono S; Matsumura Y; Handa M; Saito Y
    J Cardiovasc Surg (Torino); 2000 Dec; 41(6):935-9. PubMed ID: 11232980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfer factor immunochemotherapy for primary lung cancer--evaluation of histologic types].
    Fujisawa T; Yamaguchi Y
    Gan No Rinsho; 1983 Oct; 29(12):1409-16. PubMed ID: 6315989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.